Kayentis raises €7M ($8.3M) to accelerate the global expansion of its digital platform for clinical trials

Back Published on 02/12/2020

Kayentis, a global provider of digital data capture systems for clinical trials, today announced it had raised €7M (approx. $8.3M) in growth capital. Kayentis’ historical investors Extens and LBO France led the round, renewing their confidence in the company’s prospects and its ability to meet new expectations in the digitalization of clinical trials. Bpifrance, a new entrant, also took a stake in Kayentis’ capital.


Since 2015, the whole team has been very pleased to support Kayentis in its ambitious development and successful projects since 2015. We are reinvesting today so that the company attains the top ranks in this global market, particularly through an enlarged product offering and a strengthened commercial presence across Asia and the Americas. We also reaffirm our full confidence in the management team and its ability to execute a winning strategy.